Guardant Health

GH

2 Followers
$41.68 +4.88% $1.94
Follow
6 August
Upcoming Earnings
 
Market Cap.
 
P/E
Overview Metrics Financials
Loading...

GH Fair Price

$07.47
Undervalued by 3.7%
To display the fair price of a share, you need to be a member of Bulios Black.

My Notes

Začít psát

Profile

Guardant Health, Inc. is an American biotechnology company specializing in the development of advanced diagnostic tests for cancer detection. The company is known for its liquid biopsy technology, which allows non-invasive analysis of blood samples to identify genetic mutations and biomarkers associated with various types of cancer. Guardant Health focuses on improving early cancer detection, monitoring treatment response, and detecting recurrence, contributing to personalized oncology care and better outcomes for patients.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios

Continue with Google
Continue with Apple
Continue with Facebook
Or use email and password
Reset password
Already a member? Log in

Create Bulios profile

Continue with
Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools
Menu StockBot
Tracker
Upgrade